Evidence map›Paper›PMID 41342181›Full record

ArticleHaematologica2026

Allopurinol increases DNA-thioguanine nucleotides during maintenance therapy in pediatric acute lymphoblastic leukemia.

Jonatan Källström, Riitta Niinimäki, Johan Fredlund, Hartmut Vogt, Laura S Korhonen, Anders Castor, Kjeld Schmiegelow, Maria Thastrup, Torben Ek

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jonatan KällströmChildren's Cancer Centre, Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Pediatrics, Institute of Clinical Sciences, University of Gothenburg, Gothenburg. jonatan.kallstrom@vgregion.se.
Riitta NiinimäkiDepartment of Pediatrics and Adolescent Medicine, Oulu University Hospital, Oulu, Finland; Research Unit of Clinical Medicine, University of Oulu, Oulu.
Johan FredlundDepartment of Pediatrics, Halmstad County Hospital, Halmstad.
Hartmut VogtCrown Princess Victoria Children's Hospital, Linköping University, Linköping, Sweden; Division of Children's and Women's Health, Department of Biomedical and Clinical Sciences, Linköping University, Linköping.
Laura S KorhonenDepartment of Pediatrics, University of Turku, Turku, Finland; Department of Pediatrics and Adolescent Medicine, Turku University Hospital, Turku.
Anders CastorDepartment of Pediatrics, Skåne University Hospital, Lund University, Lund.
Kjeld SchmiegelowDepartment of Pediatrics and Adolescent Medicine, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark; Medical Faculty, Institute of Clinical Medicine, University of Copenhagen, Copenhagen.
Maria ThastrupThe Laboratory of Pediatric Oncology (Bonkolab), University Hospital Rigshospitalet, Copenhagen.
Torben EkChildren's Cancer Centre, Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Pediatrics, Institute of Clinical Sciences, University of Gothenburg, Gothenburg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41342181
PMCPMC13136827

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.